A new state law that will take effect on July 1 will make it legal for Florida farmers to grow marijuana for hemp fiber, which will bring the state in line with a recent federal law permitting the crop.
Chemicals found in hemp, like Cannabidiol (CBD), will also be legalized in Florida.
CBD is already widely sold and advertised in the state but Jacksonville attorney Sally Kent Peebles told WJCT News that federal law still prohibits CBD for many uses.
“The FDA regulates food, drugs and cosmetics and they’re saying you cannot put CBD into a product that is a food, drug or cosmetic because they haven’t tested it. And the FDA wants to make sure that CBD companies are not making egregious health claims.”
According to Kent Peebles, the FDA has said because it lacks the funding needed to shut down all CBD companies, it will concentrate on the ones touting false health benefits.
Looking for Treatment
The FDA understands that caregivers and patients are looking for treatment options for unmet medical needs. In some instances, patients or their caregivers are turning to marijuana in an attempt to treat conditions such as seizures and chemotherapy-induced nausea.
Untested Drugs can have Unknown Consequences
Over the last few decades, there has been significant interest in the potential utility of marijuana for a variety of medical conditions, including those that already have FDA-approved therapies.
More recently, several states have also passed laws that remove state restrictions on health care professionals using marijuana as a medical treatment for a variety of conditions. A number of other states are considering similar legislation regarding the use of marijuana in medical settings.
FDA Supports Sound Scientific Research
The FDA also has an important role to play in supporting scientific research into the medical uses of marijuana and its constituents in scientifically valid investigations as part of the agency’s drug review and approval process. As a part of this role, the FDA supports those in the medical research community who intend to study marijuana.
The FDA also supports research into the medical use of marijuana and its constituents through cooperation with other federal agencies involved in marijuana research. Conducting clinical research using marijuana involves interactions with other federal agencies:
- The FDA reviews the IND application and the research protocol submitted by the applicant.
- The Drug Enforcement Administration (DEA) reviews the registration application filed by the researcher.
- he National Institute on Drug Abuse (NIDA) within the National Institutes of Health provides research-grade marijuana for scientific study. The agency is responsible for overseeing the cultivation of marijuana for medical research and has contracted with the University of Mississippi to grow marijuana for research at a secure facility. Marijuana of varying potencies and compositions is available. DEA also may allow additional growers to register with the DEA to produce and distribute marijuana for research purposes.
State Legislation on Marijuana
Several states have either passed laws that remove state restrictions on the medical use of marijuana and its derivatives or are considering doing so. The FDA supports researchers who conduct adequate and well-controlled clinical trials which may lead to the development of safe and effective marijuana products to treat medical conditions. We have talked to several states, including Florida, Georgia, Louisiana, New York and Pennsylvania, who are considering support for medical research of marijuana and its derivatives to ensure that their plans meet federal requirements and scientific standards.